{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:06:17Z","timestamp":1761764777301},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"27","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CPD"],"published-print":{"date-parts":[[2006,9,1]]},"DOI":"10.2174\/138161206778343073","type":"journal-article","created":{"date-parts":[[2006,9,12]],"date-time":"2006-09-12T22:45:40Z","timestamp":1158101140000},"page":"3485-3494","source":"Crossref","is-referenced-by-count":38,"title":["Cardiovascular Effects of Phosphodiesterase 5 Inhibitors"],"prefix":"10.2174","volume":"12","author":[{"given":"Thorsten","family":"Reffelmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Kloner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/57825","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,20]],"date-time":"2015-11-20T14:11:29Z","timestamp":1448028689000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1381-6128&volume=12&issue=27&spage=3485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9,1]]},"references-count":0,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2006,9,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/138161206778343073","relation":{},"ISSN":["1381-6128"],"issn-type":[{"value":"1381-6128","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9,1]]}}}